Skip to content

Camber launches prucalopride tablets

Prucalopride tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults.

PISCATAWAY, NJ – Camber Pharmaceuticals, a leader in generic drug approvals and launches, is proud to add prucalopride tablets [proo-KAL-oh-pride] to its growing portfolio. Prucalopride Tablets are generic for Motegrity.

Prucalopride tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults. CIC affects about 10-17% of the global population and is more commonly seen in women and older adults.

Prucalopride tablets are available in 1 mg and 2 mg strengths in 30 count bottles.

To learn more about prucalopride tablets, please visit www.camberpharma.com/prucalopride

Latest

HDA honors members with 2026 DIANA Awards

HDA honors members with 2026 DIANA Awards

Established in 1959, the award honors manufacturer members for innovative products and promotions in healthcare distribution and for fostering collaborative business practices with distributor partners.